Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Tamarkin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Oncotarget|December 6, 2018
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressureSteven K Libutti, Lawrence Tamarkin, Naris Nilubol
Pure and Applied Chemistry. Chimie Pure Et Appliquee|January 20, 2015
Conformationally Constrained and Nanoparticle Targeted PaclitaxelsDavid G I Kingston, Lawrence Tamarkin, Giulio F Paciotti
Drug Delivery|June 19, 2004
Colloidal gold: a novel nanoparticle vector for tumor directed drug deliveryGiulio F Paciotti, Lonnie Myer, David Weinreich, et al.
Journal of Veterinary Internal Medicine|September 27, 2002
Endostatin concentrations in healthy dogs and dogs with selected neoplasmsJohn H Rossmeisl, Patricia Bright, Lawrence Tamarkin, et al.
International Journal of Cancer|March 3, 2007
Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factorJeffrey M Farma, Markus Puhlmann, Perry A Soriano, et al.
Annals of the New York Academy of Sciences|March 29, 2014
Nanomedicines: addressing the scientific and regulatory gapSally Tinkle, Scott E McNeil, Stefan Mühlebach, et al.
Vascular Medicine (London, England)|May 4, 2006
Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race?Carlos Iribarren, Lisa J Herrinton, Jeanne A Darbinian, et al.
Bioconjugate Chemistry|October 1, 2016
Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug DeliveryGiulio F Paciotti, Jielu Zhao, Shugeng Cao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 14, 2010
Translational considerations for cancer nanomedicineStephan T Stern, Jennifer B Hall, Lee L Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicineSteven K Libutti, Giulio F Paciotti, Adriana A Byrnes, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Oncotarget|December 6, 2018
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressureSteven K Libutti, Lawrence Tamarkin, Naris Nilubol
Pure and Applied Chemistry. Chimie Pure Et Appliquee|January 20, 2015
Conformationally Constrained and Nanoparticle Targeted PaclitaxelsDavid G I Kingston, Lawrence Tamarkin, Giulio F Paciotti
Drug Delivery|June 19, 2004
Colloidal gold: a novel nanoparticle vector for tumor directed drug deliveryGiulio F Paciotti, Lonnie Myer, David Weinreich, et al.
Journal of Veterinary Internal Medicine|September 27, 2002
Endostatin concentrations in healthy dogs and dogs with selected neoplasmsJohn H Rossmeisl, Patricia Bright, Lawrence Tamarkin, et al.
International Journal of Cancer|March 3, 2007
Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factorJeffrey M Farma, Markus Puhlmann, Perry A Soriano, et al.
Annals of the New York Academy of Sciences|March 29, 2014
Nanomedicines: addressing the scientific and regulatory gapSally Tinkle, Scott E McNeil, Stefan Mühlebach, et al.
Vascular Medicine (London, England)|May 4, 2006
Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race?Carlos Iribarren, Lisa J Herrinton, Jeanne A Darbinian, et al.
Bioconjugate Chemistry|October 1, 2016
Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug DeliveryGiulio F Paciotti, Jielu Zhao, Shugeng Cao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 14, 2010
Translational considerations for cancer nanomedicineStephan T Stern, Jennifer B Hall, Lee L Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicineSteven K Libutti, Giulio F Paciotti, Adriana A Byrnes, et al.
Pageof 2